J. Goldman & CO LP Axonics, Inc. Transaction History

J. Goldman & CO LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$35.33 - $51.04 $2.52 Million - $3.65 Million	-71,442 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$22.91 - $39.83 $1.64 Million - $2.85 Million	71,442 New	71,442 $2.51 Million
Q1 2020 May 15, 2020	SELL	$16.44 - $37.73 $6.63 Million - $15.2 Million	-403,027 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$19.57 - $28.96 $6.51 Million - $9.64 Million	332,750 Added 473.48%	403,027 $11.2 Million
Q3 2019 Nov 14, 2019	BUY	$26.92 - $42.41 $1.89 Million - $2.98 Million	70,277 New	70,277 $1.89 Million

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.